Richiedi una copia del documento: Safety evaluation of sequential mitomycin and bacillus calmette-guerin treatment versus bacillus calmette-guerin monotherapy in patients with high risk non-muscle invasive bladder cancer: mitobcg study(eudract number 2017-004540-37)preliminary results

Annulla